AAAAAA

   
Results: 1-3 |
Results: 3
Synthesis and antigenic properties of reduced peptide bond analogues of animmunodominant epitope of the melanoma MART-1 protein
Authors: Quesnel, A Zerbib, A Connan, F Guillet, JG Briand, JP Choppin, J
Citation: A. Quesnel et al., Synthesis and antigenic properties of reduced peptide bond analogues of animmunodominant epitope of the melanoma MART-1 protein, J PEPT SCI, 7(3), 2001, pp. 157-165
Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats
Authors: Lund, RD Adamson, P Sauve, Y Keegan, DJ Girman, SV Wang, SM Winton, H Kanuga, N Kwan, ASL Beauchene, L Zerbib, A Hetherington, L Couraud, PO Coffey, P Greenwood, J
Citation: Rd. Lund et al., Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats, P NAS US, 98(17), 2001, pp. 9942-9947
Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity tothe human class I histocompatibility molecule HLA-A2 by introduction of a beta-amino acid residue: Implications for recognition by tumor-infiltratinglymphocytes
Authors: Guichard, G Zerbib, A Le Gal, FA Hoebeke, J Connan, F Choppin, J Briand, JP Guillet, JG
Citation: G. Guichard et al., Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity tothe human class I histocompatibility molecule HLA-A2 by introduction of a beta-amino acid residue: Implications for recognition by tumor-infiltratinglymphocytes, J MED CHEM, 43(20), 2000, pp. 3803-3808
Risultati: 1-3 |